This article is informational and not legal advice; all case counts and regulatory figures reflect 2026 data, with pre-2026 figures labeled by year at first mention.
TL;DR — Quick Verdict
- As of August 3, 2026, 6,665 paraquat cases are pending in federal MDL 3004 before Chief Judge Nancy J. Rosenstengel, out of 8,487 total actions filed (JPML data).
- Legal analysts estimate individual settlements at roughly $100,000–$150,000, though the global deal terms remain confidential and unconfirmed.
- Two things are required to qualify: documented paraquat exposure plus a physician-confirmed Parkinson’s disease diagnosis.
- A qualified settlement fund was approved in March 2026, but a final global settlement value has not been publicly announced.
- Syngenta announced it will halt paraquat production by end of June 2026, and Vermont became the first U.S. state to ban it in May 2026.
- Recommendation: If you have a qualifying diagnosis and exposure history, consult a licensed mass-tort attorney before your state’s 2–3 year filing window closes.
More than 8,400 people have taken Syngenta and Chevron to federal court over a single claim: that repeated exposure to the herbicide paraquat caused their Parkinson’s disease. According to the U.S. Judicial Panel on Multidistrict Litigation, 6,665 of those cases remained active as of August 3, 2026, making paraquat one of the largest environmental product-liability dockets in the country. Yet unlike the Roundup litigation it is often compared to, paraquat has produced no publicly confirmed global settlement figure — only estimates, a confidential fund, and a fast-closing filing window.
This guide answers the two questions that bring most people here: do you qualify, and what might a claim be worth? Drawing on primary court records, EPA regulatory filings, and settlement analysis, the sections below break down eligibility criteria, the estimated payout range, how paraquat compares to Roundup, the mistakes that sink claims, and whether filing now is worth it. The Michael J. Fox Foundation and other advocacy groups have kept regulatory pressure on the EPA throughout this litigation — a factor shaping settlement leverage as 2026 unfolds.
Paraquat Lawsuit Status: The Numbers Behind MDL 3004
Federal paraquat claims are consolidated in the Southern District of Illinois under MDL 3004, formed in June 2021. Consolidation lets one judge manage shared discovery and settlement talks rather than thousands of duplicate trials. The docket has grown steadily even as settlement discussions advance, because Parkinson’s disease often surfaces decades after exposure.
The table below reflects the most recent official count. Note the gap between pending and total actions — the difference represents cases already resolved through dismissal or settlement.
The 2021 settlement of $187.5 million resolved an undisclosed number of early cases and did not set a per-plaintiff benchmark. Because it covered an unknown claimant pool, it cannot be divided into a reliable individual figure — a point worth remembering when you see headline “average” numbers circulating online. Those who want to understand how court dockets progress can review the typical mass tort case timelines by stage to set realistic expectations.
Who Qualifies: Exposure Plus Diagnosis
Eligibility for a paraquat claim rests on two pillars, and both must be present. First, documented exposure to paraquat — typically through occupational or agricultural handling. Second, a Parkinson’s disease diagnosis confirmed by a qualified neurologist. Missing either one generally ends a claim before it starts.
Exposure most commonly applies to licensed pesticide applicators, farmers, farmhands, and agricultural mixers and loaders, since paraquat is classified by the EPA as a Restricted Use Pesticide available only to certified users. Landscapers and, in some cases, people who lived adjacent to heavily sprayed fields and experienced drift exposure may also qualify. Consider a scenario: a 54-year-old former field worker who mixed Gramoxone between 1985 and 1998 and received a Parkinson’s diagnosis in 2023 presents a strong profile — occupational exposure, a multi-year duration, and a diagnosis window that likely falls within the statute of limitations.
Attorneys weigh strength indicators beyond the two baseline requirements. Earlier age of onset — a diagnosis in one’s 40s or 50s rather than the typical 65–70 — tends to strengthen the causation narrative because it reduces the likelihood that age alone explains the disease. Longer exposure duration also helps. Conversely, late-onset disease, exposure of only one or two years, purely secondary exposure, or genetic forms of Parkinson’s (such as LRRK2 mutations) weaken a claim. Understanding how paraquat stacks up against other toxic-exposure claims can help — compare it with PFAS water contamination lawsuit eligibility and the Camp Lejeune claim eligibility standards, both of which turn on similar exposure-documentation questions.
What Determines Your Settlement Amount
No two paraquat claims are valued identically. Because the global settlement remains confidential and unfinalized, published figures are estimates — not guarantees. Legal analysts most frequently cite a range of $100,000–$150,000 per plaintiff, a figure extrapolated from comparable herbicide litigation rather than confirmed paraquat payouts. Broader speculative ranges circulate as low as $20,000 and as high as $1.5 million, reflecting how heavily individual facts drive value.
Several factors move a claim up or down that scale. Severity of the Parkinson’s diagnosis and its effect on daily function carries the most weight. Strength of exposure evidence — employment records, purchase receipts, applicator certifications, witness testimony — comes next. Age at diagnosis, lost earning capacity, and the venue where a case is filed all factor in.
What you keep is not the gross figure. Mass-tort cases run on contingency, so attorney fees plus case costs come out of any recovery before you see it. The exact percentage for this MDL has not been publicly set, but you can apply the general framework outlined in this breakdown of mass tort attorney fee structure and net recovery to estimate your take-home from any gross figure.
Paraquat vs Roundup: Which Litigation Is Further Along?
People frequently confuse the two, but the chemicals and the cases differ sharply. Roundup’s active ingredient is glyphosate, linked to non-Hodgkin lymphoma; paraquat’s active ingredient is paraquat dichloride, linked to Parkinson’s disease. The litigation trajectories diverge just as much.
Roundup is the more mature litigation. Its manufacturer resolved roughly 100,000 claims through large-scale settlements years ago, establishing payout benchmarks that plaintiff analysts now borrow to estimate paraquat values. Paraquat, by contrast, remains in a decisive phase: Judge Rosenstengel’s ruling on general causation — whether plaintiffs’ experts can testify that paraquat causes Parkinson’s in humans — is the inflection point that will determine whether thousands of cases proceed or collapse. A separate Supreme Court case, Monsanto v. Durnell, set for oral argument on April 27, 2026, could reshape failure-to-warn claims across all herbicide litigation.
Verdict
Roundup is further along and offers established payout data, but that does not make it the “better” claim for you — the two involve entirely different injuries and chemicals. For someone with Parkinson’s and paraquat exposure, paraquat is the only relevant track. The trade-off is timing risk: paraquat’s value hinges on a causation ruling that has not yet resolved, so payouts remain estimates. Anyone weighing both should read the full Roundup lawsuit status and payout data to see how a mature herbicide settlement actually pays out.
What Most People Get Wrong About Paraquat Claims
Three mistakes derail paraquat claims more than any others. Each has a clear consequence and a clear fix.
Mistake 1: Assuming there’s plenty of time to file
Consequence: A missed statute of limitations permanently bars the claim, regardless of how strong the underlying facts are. Most agricultural states apply a 2–3 year window from diagnosis or from the date you discovered the paraquat-Parkinson’s link, though this varies and some states extend deadlines for latency diseases. Correct action: Have an attorney confirm your specific state deadline immediately rather than waiting for the global settlement to finalize.
Mistake 2: Confusing paraquat with Roundup
Consequence: Filing under the wrong litigation or citing the wrong injury weakens or invalidates a claim. Correct action: Confirm your diagnosis is Parkinson’s (paraquat) versus non-Hodgkin lymphoma (Roundup) before proceeding, and match your exposure to the correct product.
Mistake 3: Falling for unsolicited settlement “guarantees”
Consequence: Because no confirmed per-person payout exists, anyone promising a specific dollar amount is misrepresenting the litigation — and scam solicitations frequently target vulnerable claimants. Correct action: Verify any firm’s legitimacy and never pay upfront; legitimate mass-tort attorneys work on contingency. This guide to verifying mass tort claims and avoiding scam solicitations covers the specific red flags.
Is Filing a Paraquat Claim Worth It in 2026?
Whether to file comes down to conditional logic, not a blanket yes or no. Filing is likely worth pursuing if you have a physician-confirmed Parkinson’s diagnosis, documented occupational exposure, and you fall within your state’s filing window. In that situation, the estimated $100,000–$150,000 range — even after contingency fees — represents meaningful compensation for a serious, progressive disease.
Filing is weaker or not viable if your exposure was minimal or purely secondary, your diagnosis is late-onset with strong genetic markers, or your filing window has already closed. The regulatory and corporate backdrop, however, favors claimants generally: the EPA delayed its final paraquat decision on January 17, 2025, citing the need for additional data on volatilization risk; Syngenta announced in March 2026 it will halt paraquat production by end of June 2026; and Vermont became the first state to ban the herbicide when Governor Scott signed H.739 in May 2026. Companies rarely abandon flagship products and rush to settle if they expect to win at trial.
The counterweight is genuine uncertainty. No global settlement value has been publicly confirmed, and the causation ruling could still reshape case economics. If you are comparing this against other active dockets to gauge relative strength, the projections in the NEC baby formula settlement projections and the talcum powder lawsuit settlements and deadlines offer useful benchmarks for how mid-stage mass torts resolve. It also helps to understand the structural difference explained in mass tort vs class action payouts, since paraquat is a mass tort where each plaintiff retains an individual claim rather than sharing one pooled recovery.
Frequently Asked Questions
How many paraquat lawsuits are currently pending?
As of August 3, 2026, 6,665 paraquat cases were pending in MDL 3004 in the Southern District of Illinois, out of 8,487 total actions filed since the litigation was consolidated in June 2021, according to the U.S. Judicial Panel on Multidistrict Litigation. The docket continues to grow as new claims are filed, even amid settlement discussions.
What is the average paraquat settlement amount?
No confirmed average exists yet because the global settlement terms are confidential. Legal analysts most often estimate $100,000–$150,000 per plaintiff, extrapolated from comparable herbicide litigation, with broader speculative ranges from $20,000 to $1.5 million. Actual value depends on diagnosis severity, exposure evidence, age, and venue, so treat all published figures as estimates rather than guarantees.
Is there a deadline to file a paraquat claim?
Yes. Most agricultural states apply a 2–3 year statute of limitations running from your Parkinson’s diagnosis or from when you discovered the paraquat link, though deadlines vary and some states extend them for latency-based diseases. Because a missed deadline permanently bars a claim, confirming your specific state window with a licensed attorney promptly is essential.
Is paraquat banned in the United States?
Not federally, though its status is shifting. Paraquat remains a Restricted Use Pesticide available only to certified applicators. Vermont became the first state to ban it when Governor Scott signed H.739 in May 2026, and Syngenta announced it would stop producing paraquat by the end of June 2026. The EPA delayed its final regulatory decision in January 2025, pending additional data.
How We Researched This Article
The figures in this article were drawn primarily from official government and court records. The pending and total case counts for MDL 3004 come directly from the U.S. Judicial Panel on Multidistrict Litigation’s MDL Statistics Report dated August 3, 2026, which publishes actions-pending distributions for every active federal multidistrict litigation. We fetched that primary PDF rather than relying on secondary summaries, and calculated the resolved-case figure (1,822) by subtracting pending from total historical actions. Regulatory status was verified against the U.S. Environmental Protection Agency’s paraquat dichloride resource pages and the Federal Register, including the agency’s January 2024 interim documents and its January 17, 2025 delay of final action. Settlement history — the 2021 figure of $187.5 million — traces to Syngenta’s corporate reporting as reproduced in litigation coverage.
Settlement value ranges are the least certain data in this article and are explicitly modeled, not measured. Because the global paraquat settlement terms remain confidential, we present analyst estimates as ranges and label them as such, applying our fallback methodology rather than asserting a single point figure. Eligibility criteria and statute-of-limitations periods were synthesized from multiple plaintiff-firm sources and cross-checked for consistency; because these vary by state, they are described as ranges. Primary sources consulted include the U.S. Judicial Panel on Multidistrict Litigation, the U.S. Environmental Protection Agency, and the Federal Register. This analysis was last conducted in August 2026. Litigation figures change monthly, and readers should verify current counts against the named sources before acting. All figures were verified against named primary sources before publication.